通过排泄抑制剂对抗多药耐药性真菌
1Department of Natural Products, Chemical Sciences, National Institute of Pharmaceutical Education and Research-Hyderabad, Hyderabad, Balanagar 500037, India.
Biochemical pharmacology
|June 30, 2024
概括
耐多药真菌构成了重大威胁. 本综述探讨了诸如排泄抑制剂之类的策略,通过阻断药物排放和使真菌对现有治疗敏感来对抗抗真菌抵抗.
科学领域:
- 菌类学 菌类学是指菌类学.
- 抗微生物耐药性 抗微生物耐药性
- 药物发现 药物发现 药物发现
背景情况:
- 耐多药性真菌感染是一个日益严重的全球健康问题,特别是对于免疫力低下的人来说.
- 目前的抗真菌治疗方法 (阿佐尔,聚烯,乙甘) 面临着由于真菌机制如排泄过度表达的日益增长的耐药性.
- 人类和植物病原体使用抗真菌药物的重叠加剧了耐药性的发展.
研究的目的:
- 审查克服外流介导抗真菌耐药性的新策略.
- 突出自然化合物,重用药物和配方方法作为潜在的解决方案.
- 解决迫切需要新的抗真菌剂,针对不同的途径.
主要方法:
- 文献综述侧重于真菌中的排泄机制.
- 对天然产品和现有的药物进行分析,这些药物有可能抑制排水.
- 探索配方策略,以提高抗真菌药物的疗效.
主要成果:
- 溢流的过度表达是降低细胞内药物度的关键机制,导致耐药性.
- 抑制排泄可以恢复对现有的抗真菌药物的敏感性.
- 自然的分子,重新定制的药物和先进的配方在克服抵抗方面显示出有前途.
结论:
- 针对真菌排泄是一种有效的策略,可以对抗多药性耐药性.
- 组合疗法和排泄抑制剂可以增强当前抗真菌药物的有效性.
- 进一步研究天然产品,药物的重新用途和新型配方对于开发新的抗真菌治疗非常重要.
关键词:
这是一张ATP结合卡塞特.这是一种抗真菌药物.亚醇是一种醇.埃奇诺坎迪因 (echinocandins) 是一种类型.排水是一种排水.主要促进者的家庭.自然产品是天然产品.聚烯是一种多烯.可重新使用的药物.更多相关视频
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
581
08:45Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
13.8K
相关概念视频
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Pulmonary Tuberculosis V
177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
